IL22 and inflammatory bowel disease: IL-22BP expression is reduced in infectious colitis but not in inflamed tissues in IBD, indicating potential pathophysiological significance for IL-22BP-dependent alterations in IL-22 bioactivity [220,228].These responses may vary between patients and differ according to the extent of histological damage.